Cytek Biosciences, Inc. CTKB Interest expenses for accretion of the legal settlement liabilities
Interest expenses for accretion of the legal settlement liabilities at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept ctkb:InterestExpensesForAccretionOfLegalSettlementLiabilities.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s interest expenses for accretion of the legal settlement liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s interest expenses for accretion of the legal settlement liabilities?
- Cytek Biosciences, Inc. (CTKB) reported interest expenses for accretion of the legal settlement liabilities of -$47K in Q1 2026.
- How has Cytek Biosciences, Inc.'s interest expenses for accretion of the legal settlement liabilities changed year-over-year?
- Cytek Biosciences, Inc.'s interest expenses for accretion of the legal settlement liabilities decreased by 131.8% year-over-year, from $148K to -$47K.
- What is the long-term trend for Cytek Biosciences, Inc.'s interest expenses for accretion of the legal settlement liabilities?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s interest expenses for accretion of the legal settlement liabilities has grown at a -33.6% compound annual growth rate (CAGR), from $1.69M to -$328K.
- What does interest expenses for accretion of the legal settlement liabilities mean?
- Reflects the non-cash interest expense recognized as the present value of a legal settlement liability increases over time toward its ultimate settlement amount. This metric highlights the financial cost associated with long-term legal obligations and their impact on periodic earnings.